Search
for
Sort by
Research 181–210 of 1000+
- The pattern of off-label and unlicensed drug use in adult and pediatric patients in the Kingdom of Saudi Arabia: multicenter retrospective study
- FDA-Approved (Bremelanotide, Flibanserin) and Off-Label Medications (Testosterone, Sildenafil) to Enhance Sexual Desire/Function in Women
- Impact of a health alert and its implementation on flutamide prescriptions for women: an interrupted time series analysis
- Open-label placebos reduce hair cortisol concentrations and psychological distress - a randomized controlled trial
- Bariatric surgery for spontaneous ovulation in women living with polycystic ovary syndrome: the BAMBINI multicentre, open-label, randomised controlled trial
- Janus Kinase Inhibitors in the Treatment of Alopecia Areata
- 9-cis-Retinoic Acid Capsules in the Treatment of AIDS-Related Kaposi Sarcoma
- Stem Cells and their Niches
- Context-dependent effect of sPLA2-IIA induced proliferation on murine hair follicle stem cells and human epithelial cancer
- Topical Treatments for Scalp Psoriasis
- An Open-Label Pilot Study to Evaluate the Efficacy of Tofacitinib in Moderate to Severe Patch-Type Alopecia Areata, Totalis, and Universalis
- Successful discontinuation of levothyroxine in a known case of hypothyroidism through personalised homoeopathic treatment: An evidence-based case report
- An Open-Label Comparative Study on the Effects of Platelet-Rich Plasma Therapy with Hydroquinone 4% Versus Hydroquinone 4% Alone in Melasma
- Ageratum Conyzoides L. Extract Inhibits 5α-Reductase Gene Expression and Prostaglandin D2 Release in Human Hair Dermal Papilla Cells and Improves Symptoms of Hair Loss in Otherwise Healthy Males and Females in an Open Label Pilot Study
- Use of 5% Topical Minoxidil Application for Telogen Effluvium: An Open‐Label Single‐Arm Clinical Trial
- Effect of rinse-off hair conditioner containing argan oil or camellia oil on the recovery of hair damaged by bleaching
- Unraveling Ritlecitinib: an in-depth analysis of JAK3 inhibitor for the treatment of alopecia areata
- Long‐term safety and efficacy of ritlecitinib in adults and adolescents with alopecia areata and at least 25% scalp hair loss: Results from the ALLEGRO‐LT phase 3, open‐label study
- Gender differences in adverse effects and dosing practices of low-dose oral minoxidil for androgenetic alopecia: a retrospective analysis of 310 patients
- Therapeutic Use of Botulinum Neurotoxins in Dermatology: Systematic Review
- Characteristics and Outcomes of Patients on Tofacitinib for Alopecia Areata or Rheumatoid Arthritis: A Retrospective Cohort Study
- Minoxidil Beyond Hair: A Comprehensive Review of Its Effects on Nail Growth
- Efficacy of Skin Patting and Iontophoresis with Dutasteride Gel in Male and Menopausal Female Androgenetic Alopecia: A Pilot Study
- TOPICAL MINOXIDIL THERAPY FOR ANDROGENIC ALOPECIA IN THE MIDDLE EAST
- LabeledIn: Cataloging labeled indications for human drugs
- Contraindicated use of 5-alpha-reductase inhibitors in women
- Nurses' Drug Alert
- Topical L‐thyroxine: The Cinderella among hormones waiting to dance on the floor of dermatological therapy?
- A Real‐World Disproportionality Analysis of Avacopan in Anti‐Neutrophil Cytoplasmic Antibodies Associated Vasculitis: Insights From FDA Adverse Event Reporting System
- Freeze-Drying of Platelet-Rich Plasma: The Quest for Standardization